Tissue factor and its inhibitor in human non-crescentic glomerulonephritis - Immunostaining vs plasma and urinary levels

Nephrology Dialysis Transplantation

Volumn 21, Issue 12, 2006, Pages 3450-3457

  Naumnik, Beata ^a   Borawski, Jacek ^a   Chyczewski, Lech ^a   Pawlak, Krystyna ^a   Mysliwiec, Michal ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Glomerulonephritis; Immunohistochemistry; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

CREATININE; PEROXIDASE; PLACENTA PROTEIN 5; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CELL PROLIFERATION; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE CLEARANCE; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS; HISTOCHEMISTRY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY TUBULE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; URINALYSIS;

ADOLESCENT; ADULT; AGED; BIOPSY; FEMALE; GLOMERULONEPHRITIS; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS; MALE; MIDDLE AGED; THROMBOPLASTIN;

EID: 33751409881     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl365     Document Type: Article

References (20)

1. Lwaleed BA. Tissue factor: Biological function and clinical significance. Saudi Med J 2002; 23: 135-143
2. Johnson K, Zaror I, Bauer D, Choi Y, Creasey A, Innis M. Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor. Thromb Haemost 1998; 80: 585-587
3. Shinoda E, Yui Y, Hattori R et al. Tissue Factor Pathway Inhibitor-2 is a novel mitogen for vascular smooth muscle cells. J Biol Chem 1999; 9: 5379-5384
4. Grandaliano G, Gesualdo L, Ranieri E, Manno R, Schena FP. Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis. Am J Kidney Dis 2000; 4: 726-738
5. Cunningham MA, Ono T, Hewitson TD, Tipping PG, Becker GJ, Holdsworth SR. Tissue factor pathway inhibitor expression in human crescent glomerulonephritis. Kidney Int 1999; 55: 1311-1318
6. Tipping PG, Dowling JP, Holdsworth SR. Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest 1988; 81: 119-125
7. Erlich JH, Holdsworth SR, Tipping PG. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulo-nephritis. Am J Pathol 1997; 150: 873-880
8. Cunningham MA, Kitching AR, Tipping PG, Holdsworth SR. Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritis. Kidney Int 2004; 66: 647-654
9. Lwaleed BA. Is tissue factor a mediator of fibrin deposition in glomerular pathology? Nephrol Dial Transplant 1599; 14: 2533
10. Tipping PG, Erlich JH, Apostolopoulos J, Mackman N, Loskutoff D, Holdsworth SR. Glomerular tissue factor expression in crescentic glomerulonephritis. Correlation between antigen, activity, and mRNA. Am J Pathol 1995; 147: 1736-1748
11. Lwaleed BA, Bass PS, Rogerson ME, Francis JL, Chisholm M. Effect of kidney function and disease status on urinary tissue factor measurements. J Clin Pathol 1998; 51: 234-237
12. Lwaleed BA, Bass PS, Chisholm M, Francis JL. Urinary tissue factor in glomerulonephritis: A potential marker of glomerular injury? J Clin Pathol 1997; 50: 336-340
13. Fleck RA, Vijaya Mohan Rao L, Rapaport SI, Varki N. Localization of human tissue factor antigen by immuno-staining with nonospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 59: 421-437
14. Erlich JH, Apostolopoulos J, Wun TC, Kretzmer KK, Holdsworth SR, Tipping PG. Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits. J Clin Invest 1996; 98: 325-335
15. Osterud B, Bajaj MS, Bajaj SP. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. Thromb Haemost 1995; 73: 873-875
16. Howie AJ, Ferreira MAS, Adu D. Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol Dial Transplant 2001; 16: 1163-1169
17. Waller DG, Fleming JS, Ramsey B, Gray J. The accuracy of creatinine clearance with and without urine collection as a measure of glomerular filtration rate. Postgrad Med J 1991; 67: 42-46
18. Gutierrez E, Gonzalez E, Morales E et al. Antiproteinuric effect of renin-angiotensin system blockade in patients with normal/lower than 115 mmHg systolic blood pressure. Nefrologia 2004; 24: 546-552
19. Gryglewski RJ, Uracz W, Swies J et al. Comparison of endothelial pleiotropic actions of angiotensin converting enzyme inhibitors and statins. Ann N Y Acad Sci 2001; 947: 229-246
20. Chabielska E, Mogielnicki A, Kramkowski K, Buczko W. Antithrombotic effect of captopril and enalapril in old rats. Pharmacol Rep 2005; 57: 135-137